Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03956654 |
Title | A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB) |
Acronym | RibOB |
Recruitment | Completed |
Gender | female |
Phase | FDA approved |
Variant Requirements | No |
Sponsors | Universitaire Ziekenhuizen Leuven |
Indications | |
Therapies | |
Age Groups: | senior |
Covered Countries | BEL |